Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice

Open Access

Peer-reviewed

Research Article

Viviana Buffa,

Affiliation Clinical Sciences, St. George's University of London, London, United Kingdom
⨯
Katja Klein,

Affiliation Clinical Sciences, St. George's University of London, London, United Kingdom
⨯
Lucia Fischetti,

Affiliation Clinical Sciences, St. George's University of London, London, United Kingdom
⨯
Robin J. Shattock

* E-mail: r.shattock@imperial.ac.uk

Affiliation Clinical Sciences, St. George's University of London, London, United Kingdom
⨯

Reader Comments (0)

Immunologic adjuvants
Is the Subject Area "Immunologic adjuvants" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Tetanus
Is the Subject Area "Tetanus" applicable to this article?

Thanks for your feedback.
Toxoids
Is the Subject Area "Toxoids" applicable to this article?

Thanks for your feedback.
Routes of administration
Is the Subject Area "Routes of administration" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Toll-like receptors
Is the Subject Area "Toll-like receptors" applicable to this article?

Thanks for your feedback.
Antigens
Is the Subject Area "Antigens" applicable to this article?

Thanks for your feedback.